Thomas Jefferson University

Jefferson Digital Commons
Department of Anesthesiology Faculty Papers

Department of Anesthesiology

5-2019

Letter to the Editor: Ketamine for pain management: Let's not
neglect practical concerns
Steven P. Cohen
Johns Hopkins School of Medicine; Uniformed Services University of the Health Sciences

Eric S. Schwenk
Thomas Jefferson University

Eugene R. Viscusi
Thomas Jefferson University

Follow this and additional works at: https://jdc.jefferson.edu/anfp
Part of the Anesthesiology Commons

Let us know how access to this document benefits you
Recommended Citation
Cohen, Steven P.; Schwenk, Eric S.; and Viscusi, Eugene R., "Letter to the Editor: Ketamine for
pain management: Let's not neglect practical concerns" (2019). Department of Anesthesiology
Faculty Papers. Paper 51.
https://jdc.jefferson.edu/anfp/51
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital
Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is
a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections
from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested
readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been
accepted for inclusion in Department of Anesthesiology Faculty Papers by an authorized administrator of the
Jefferson Digital Commons. For more information, please contact: JeffersonDigitalCommons@jefferson.edu.

Correspondence

Letter to the Editor: Ketamine for pain
management: let’s not neglect practical concerns
Downloaded from https://journals.lww.com/painrpts by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3vZhfaAjmmeO4SyuXG/7LREpRRVC2r/n8U8x3zR8J9PXu6iB71/jMzA== on 09/18/2019

Steven P. Cohena,b, Eric S. Schwenkc, Eugene R. Viscusic, on behalf of the American Society of Regional Anesthesia
& Pain Medicine and American Academy of Pain Medicine Ketamine Guidelines Committees

We read with interest the recent article on ketamine by Bell and
Kalso.1 In recent years, the use of ketamine to treat chronic pain
and depression has exploded, and this article represents an
easy-to-follow overview of this often misunderstood medication.
In their article, the authors focus on systematic reviews to draw
broad conclusions on acute and chronic pain, without delving into
the specifics of studies, including selection criteria and limitations.
Although this methodology is sufficient for a topical review that
summarizes basic information to include mainstream generalizations about efficacy and side effects, it is not capable of
providing clinicians with practical recommendations that can be
used to guide care such as indications and contraindications,
dose regimens, benefit as an adjunct to opioids for acute pain,
evidence for follow-up therapy with oral ketamine and other Nmethyl-D-aspartate antagonists, how often and in whom to repeat
procedures, how to prevent and treat adverse effects, and
practical concerns such as how and by whom these patients
should be monitored.
For both acute and chronic pain, this information and more is
provided in recent guidelines along with a narrative review
developed in a joint effort by the American Society of Regional
Anesthesia & Pain Medicine, the American Academy of Pain
Medicine, and the American Society of Anesthesiologists.2,3
Considering that anesthesiologists (not to mention other clinicians)
comprise a plurality of International Association for the Study of
Pain membership, these pragmatic concerns have clinical
relevance for the Journal’s readership. We assume the time frame
of this publication, which was revised and accepted in June 2018,
prevented the inclusion of these guidelines, but would encourage
readers interested in the practical elements of intravenous
ketamine use for pain treatment to explore these resources.
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